Foundayo (with the core ingredient Orforglipron) is a once-daily small molecule (non-peptide) oral GLP-1 receptor agonist, The "small molecule" is actually important to keep in mind, because unlike Semaglutide, which is a peptide drug requiring strict handling conditions, Orforglipron is a small molecule, meaning it follows standard small-molecule chemistry and doesn't require the same formulation complexity as peptide-based GLP- Foundayo was FDA approved on April 1st, really no joke
10.1039/c9bm01284b Summary Keywords cell transfection, glutathione S-transferase, glutathione, GPI, cell sorting Citation Ma S, Yang L, Zuo Q and Huang Q (2022) GPI-anchored glutathione S-transferase as marker allows affinity sorting of transfection-positive cells
It can be an opportunity to pick up new presentations, or help people to understand the extent of their behaviour, she says
Which version provides better results